Testing a decision-support tool for cancer trial choices
Part of Cancer clinical trials.
This study tests a tool to help patients with throat or voice box cancer decide whether to join a larger trial. It aims to make the decision process clearer and less overwhelming.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cancer of the pharynx or larynx (throat or voice box).
- You have already been told about the DAHANCA 35 trial and read its information folder.
- You are 18 years or older.
- You speak Danish.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to help people with cancer and their doctors make decisions together. If you have prostate, breast, or melanoma cancer, this trial may help you understand your options better.
This study is testing a tool called TA-DA to help patients with advanced cancer and their caregivers make decisions about further treatment after at least two prior therapies. It aims to improve shared decision-making.
This study tests a digital tool that uses pictures and simple visuals to help you understand your cancer treatment options. The goal is to make the experience better for you, your family, and your doctors.
This trial is testing a decision aid to help women newly diagnosed with breast cancer choose between different surgery options. It looks at how well this tool supports you in making a choice that fits your values and preferences.
This study tests whether a decision-making tool helps patients with low-risk thyroid cancer or suspicious thyroid nodules (small lumps) feel more confident about their treatment choices. The tool is designed to help you understand your options before meeting with a surgeon.
This study is testing a tool to help you and your doctor make decisions together about whether to have extra treatment after surgery for non-small cell lung cancer (stage 1B or higher). It only includes patients at Mayo Clinic in Rochester who are eligible for that extra treatment.
Hear when a new Head and Neck Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.